(Date:10/11/2008)...ernational Transcends Cultural Divides, JOHANNESB...frican and,international audiences welcome Bishop ...fying gathering, which for the first time is being...tp://www.newscom.com/cgi-bin/prnh/20081011/CLSA011...off with performances by,South Africa,s own multi-...
(Date:10/10/2008)...10 /PRNewswire-FirstCall/ -- Synvista,Therapeutics...ed William,(Bill) Federici, 49, to its Board of Di.... Federici joined West Pharmaceutical Services as ...st of 2003. Under his financial leadership,West P...1.0 billion from,$300 million. He has more than 20...
(Date:10/10/2008)...rving as tipping point for behavior change, DES M...e than half of,Americans (51 percent) believe ther...stem, but major changes are needed, according to t...was released today by the,Employee Benefit Researc...c., and was underwritten by the Principal Financia...
(Date:10/10/2008)...Calif., Oct. 10 /PRNewswire/ -- A senior citizen,s...ountains in a small,plane. The high-flying adventu.... The thrill came from a last-wish program through...nior Living, where Heden was a patient.,Called Go ...it has helped,many realize a special activity at t...
Breaking Medicine News(10 mins):Health News:Bishop T.D. Jakes Electrifies South Africa 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Deck of Cards is More Than a Game: Integral in Silverado Hospice Care 2...pt to tackle the global threat from bird flu, it h...atories as it is felt that// it may provide the be... to set up such a system has been published in the...nal. Improved surveillance measures through co-or...
...ney Disease or (CKD) seems to be household disease... as world kidney day. India’s record of 20milion d...iabetes and worse,// with one in every three diabe...WHO has also sounded a warning that these figures ...
...from the National Institute of Dental and Craniofa...ies of Washington and Illinois, the Center for Dis... Statistics will assess the progress made towards ...d Health Communication Objectives" (HP 2010) at th...
...ton, a great grandfather at 79 and a war veteran, ... but quite unfortunately, met his end at the hand...potent sedative purported to give him a good night... Julia Levitt, 28, of unlawfully killing Kenneth H...
Other Medicine News:(Date:10/8/2008)...ontinued and Headcount to be Reduced, Summary: Gen... Zanolimumab Program to be Discontinued and the C... Employees, COPENHAGEN, October 8 /PR...nced today that it is discontinuing development of...ult of a portfolio review and,assessment of the or...
(Date:10/8/2008)...Poly-ICR as Vaccine Adjuvant, SAN DIEGO, Oct. 8 /...,Corporation (TSX: NVN) today presented positive d... Toll-like Receptor 3 agonist, Poly IC-Poly,Argini...in Lyon, France.,Study results demonstrated Poly-I...oll-like Receptor 3 (TLR3) pathway. Data showed th...
(Date:10/7/2008)...Prometheus Laboratories Inc., a,specialty pharmace...development of PROMETHEUS(R) IBS Diagnostic, the f...ome (IBS). The findings suggest measurable,differe... blood samples,between IBS and non-IBS patients. T...th a proprietary algorithm, led to the development...
(Date:10/7/2008)... -- The Texas Cardiac Arrhythmia,Institute (TCAI) ... one of,only a few sites in the nation to particip...vice to treat persistent atrial fibrillation. TCAI...h center specializing in heart,rhythm disorders, i... and,Texas Cardiovascular Consultants., "This is ...
Breaking Medicine Technology:Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2Heart Disease Deaths Over Reported in New York City 12523 1Heart Disease Deaths Over Reported in New York City 12523 2LeMaitre Vascular Inc Schedules Fourth Quarter Results and Conference Call 12519 1Most Internet Sex Offenders Target Teens Not Kids 12516 1Most Internet Sex Offenders Target Teens Not Kids 12516 2Most Internet Sex Offenders Target Teens Not Kids 12516 3Key Business Labor and Academic Experts Join Stop Obesity Alliance Panel to Present Policy Perspectives and Recommendations to Reshape The Union 12512 1Key Business Labor and Academic Experts Join Stop Obesity Alliance Panel to Present Policy Perspectives and Recommendations to Reshape The Union 12512 2...munization with a Bavituximab Equivalent and Irrad...57% From 0% in Controls in a,Preclinical Model of ...ril 18, 2007,/PRNewswire-FirstCall/ -- Peregrine P...eutical company developing targeted,monoclonal ant...C,virus (HCV) infection, today announced preclinic...
...-2 Antagonist shown to be therapeutically effectiv...a , COPENHAGEN, 18 April 2007 - Santaris Pharma, t...i drugs, yesterday,presented encouraging data at t... Meeting in Los Angeles, showing that SPC2996, the...ally active in a,preclinical model of human Chroni...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6The SF-3000 automated hematology analyzer can provide accurate and precise 23-parameter hematolgy results including a fully automated WBC 5-part differential from a compact space-save design.
The XE-2100L automated hematology analyzer features new hematology parameters as NRBC, IRF, and HPC that offer valuable and accurate clinical information.
HmX offers three-dimensional VCS technology, providing excellent sensitivity, specificity and efficiency in white cell differential and reticulocyte analysis. With its reputation for accuracy and dep
The CKX microscopes utilize the infinity-corrected optical system for improved visibility and operability in cell checking. The CKX31 is a cost-effective inverted microscope suited to routine applica
Medicine Products: